ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,295.32
-0.03%
US Tech 100
18,055.58
-0.13%
다우존스 지수
39,927.52
0.15%
Bitcoin
66,635.68
2.14%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Arrowhead Pharmaceuticals Inc (ARWR)

  7. Arrowhead Pharmaceuticals Inc (ARWR) 뉴스

ARWR

Arrowhead Pharmaceuticals (ARWR)

Arrowhead Pharmaceuticals Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:ARWR
일자시간출처헤드라인심볼기업
2024/05/1005:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARWRArrowhead Pharmaceuticals Inc
2024/05/0707:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
2024/04/1622:00GlobeNewswire Inc.Turnstone Biologics Appoints William Waddill to its Board of DirectorsNASDAQ:ARWRArrowhead Pharmaceuticals Inc
2024/03/0907:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
2024/03/0707:30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
2024/02/2807:08Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ARWRArrowhead Pharmaceuticals Inc
2024/02/0706:13Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ARWRArrowhead Pharmaceuticals Inc
2024/02/0706:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARWRArrowhead Pharmaceuticals Inc
2024/02/0307:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
2024/02/0106:57Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
2024/01/2707:28Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ARWRArrowhead Pharmaceuticals Inc
2024/01/1808:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
2024/01/1807:22Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:ARWRArrowhead Pharmaceuticals Inc
2024/01/1708:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
2024/01/1708:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
2024/01/1708:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
2024/01/1708:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
2024/01/1306:16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
2024/01/1206:48Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
2024/01/1206:38Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
2024/01/1206:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
2024/01/1206:05Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
2024/01/0907:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
2024/01/0907:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
2024/01/0907:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
2024/01/0610:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
2024/01/0609:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
2024/01/0607:33Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
2024/01/0607:14Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
2024/01/0606:58Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
 검색 관련기사 보기:NASDAQ:ARWR

최근 히스토리

NYSE
NKE
Nike
CCOM
US30
US 30
NASDAQ
QQQ
Invesco QQQ Trust Series 1
PM
XAUUSD
Gold vs US Dollar
USI
USTECH100
US Tech 100
NASDAQ
NVDA
NVIDIA
NYSE
VZ
Verizon Communications
NYSE
KO
Coca Cola
NASDAQ
MSFT
Microsoft
NASDAQ
AAPL
Apple
NYSE
AXP
American Express
FX
USDEUR
US Dollar vs Euro
NYSE
BAC
Bank of America
AMEX
XLF
Financial Select Sector
COIN
ETHUSD
Ethereum
NASDAQ
GOOGL
Alphabet
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유